Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity

Clin Case Rep. 2021 Feb 22;9(4):2132-2137. doi: 10.1002/ccr3.3964. eCollection 2021 Apr.

Abstract

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.

Keywords: COVID‐19 infection; Nepal; convalescent plasma therapy; multimorbidity.

Publication types

  • Case Reports